If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,664.00    -4.00 (-0.15%)
Bid:
2,642.00
Ask:
2,644.00
Spread: 2.00 (0.076%)
Market Cap: £8.55b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

Acquisition

27 Feb 2017 07:00

RNS Number : 8421X
Bunzl PLC
27 February 2017
Β 

27 February 2017

Β 

BUNZL EXPANDS INTO SINGAPORE

Β 

Bunzl plc, the international distribution and outsourcing Group, today announces that it has acquired LSH, a company based in Singapore.

Β 

LSH is engaged in the distribution of a variety of personal protection equipment, primarily to end users operating in the oil & gas, construction, pharmaceutical and industrial sectors. Revenue in 2016 was S$9 million (c.Β£5 million).

Β 

Commenting on the acquisition, Frank van Zanten, Chief Executive of Bunzl, said:

Β 

"The purchase of LSH represents our first step into Singapore following which we now have operations across 30 countries globally. The business has a leading position in the local safety market with a broad product offering and well established customers and should provide a good base from which to develop our operations in South East Asia. We are pleased to welcome their employees to the Group".

Β 

Β 

Β 

Enquiries:

Β 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Stephen Malthouse

Tel: +44 (0)20 7353 4200

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQTIMFTMBMTBPR
Date   Source Headline
1st Mar 20174:27 pmRNSTotal Voting Rights
1st Mar 20177:00 amRNSAcquisition
27th Feb 20171:30 pmRNSDividend Declaration
27th Feb 20177:00 amRNSDirectorate Change
27th Feb 20177:00 amRNSAcquisition
27th Feb 20177:00 amRNSFinal Results
3rd Feb 20175:37 pmRNSDirector/PDMR Shareholding
1st Feb 20173:27 pmRNSTotal Voting Rights
18th Jan 20175:02 pmRNSDirector/PDMR Shareholding
10th Jan 20177:00 amRNSAcquisition
6th Jan 201712:00 pmRNSDirector/PDMR Shareholding
3rd Jan 201710:43 amRNSTotal Voting Rights
28th Dec 20162:00 pmRNSHolding(s) in Company
19th Dec 20162:55 pmRNSHolding(s) in Company
15th Dec 20167:00 amRNSTrading Statement
12th Dec 20164:22 pmRNSHolding(s) in Company
9th Dec 20164:15 pmRNSHolding(s) in Company
1st Dec 20169:00 amRNSTotal Voting Rights
23rd Nov 20165:16 pmRNSDirector/PDMR Shareholding
22nd Nov 20167:00 amRNSAcquisition
1st Nov 20164:58 pmRNSBlock listing Interim Review
1st Nov 20164:49 pmRNSTotal Voting Rights
26th Oct 20167:00 amRNSTrading Statement
11th Oct 20165:15 pmRNSDirector/PDMR Shareholding
11th Oct 20164:38 pmRNSDirector/PDMR Shareholding
7th Oct 20164:44 pmRNSDirector/PDMR Shareholding
3rd Oct 201611:37 amRNSTotal Voting Rights
26th Sep 20163:45 pmRNSDirector/PDMR Shareholding
21st Sep 20164:12 pmRNSDirector/PDMR Shareholding
14th Sep 20165:07 pmRNSDirector/PDMR Shareholding
13th Sep 201610:38 amRNSDirectorate Change
5th Sep 20163:13 pmRNSHolding(s) in Company
2nd Sep 20163:13 pmRNSDirector/PDMR Shareholding
1st Sep 201611:11 amRNSTotal Voting Rights
30th Aug 20164:55 pmRNSDirector/PDMR Shareholding
30th Aug 20169:30 amRNSDividend Declaration
30th Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSAcquisition
1st Aug 20169:31 amRNSTotal Voting Rights
29th Jul 201610:08 amRNSDirectorate Change
15th Jul 20164:32 pmRNSDirector/PDMR Shareholding
5th Jul 20161:20 pmRNSDirector/PDMR Shareholding
4th Jul 201610:37 amRNSHolding(s) in Company
1st Jul 20161:13 pmRNSTotal Voting Rights
1st Jul 201612:16 pmRNSHolding(s) in Company
30th Jun 20163:48 pmRNSDirector/PDMR Shareholding
29th Jun 20164:36 pmRNSDirector/PDMR Shareholding
29th Jun 201610:12 amRNSHolding(s) in Company
29th Jun 20167:00 amRNSTrading Statement
27th Jun 20169:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.